Digital Transformation Benchmarking Index for Pharmaceutical Manufacturers
Presentation | 1Q 2026 | PT-6041
| 出版 | ABI Research |
| 出版年月 | 2026年02月 |
| ページ数 | 21 |
| ベーシックライセンス | USD 1,950 |
| 種別 | 英文調査報告書 |
| 商品番号 | SMR- |
リサーチハイライト
- デジタル成熟度とデジタル投資の影響度に基づいた大手製薬メーカーのマトリックス分類。
- 製薬メーカーとの連携に関する戦略的提言。
- 製薬業界が直面する課題への取り組み方に関する詳細な評価。
- 主要企業がデジタル技術を活用して従業員の能力向上を図った事例。
当レポートは下記年間契約サービスに属する市場レポートです。
- 産業&製造市場のリサーチサービス
Industrial & Manufacturing Markets Research Service
ABIリサーチの年間サービスは特定市場の最新・詳細情報をPDFレポート、EXCELファイル、ニューズレターなどを一年を通じて契約者へ提供しています。当レポート単体でもご購入いただけますが、年間サービスのご契約により、継続的に市場情報を入手いただけます。詳細はお気軽にお問い合わせください。
Actionable Benefits
- Understand which pharmaceutical manufacturers are leading the way, both in terms of implementing digital technologies, and more importantly, generating tangible benefits from such investments.
- Identify which pharmaceutical manufacturers’ digital initiatives are helping them meet the challenges that the industry faces.
- Identify the solutions that are meeting the industry’s challenges.
Research Highlights
- Matrix grouping of the largest pharmaceutical manufacturers by digital maturity and impact of digital investments.
- Strategic recommendations about engaging with pharmaceutical manufacturers.
- A detailed assessment of ways that pharmaceutical manufacturers are approaching the challenges the industry faces.
- Use cases outlining how leading firms have utilized digital technologies to improve the workforce.
Critical Questions Answered
- What types of digital initiatives are having an impact on pharmaceutical manufacturers?
- Which pharmaceutical manufacturers stand out in terms of digital maturity?
- What are some of the most impactful use cases that technology suppliers should get behind to help their pharmaceutical customers?
Who Should Read This?
- Strategists responsible for improving how their organizations engage with pharmaceutical manufacturers.
- System integrators that need to identify use cases that may be applicable at their pharmaceutical client sites.
- Marketing leaders looking to target pharmaceutical manufacturers.
- Digital leaders at pharmaceutical manufacturers looking to obtain insights covering how different digital technologies can support their operations and to compare themselves with peers.
Table of Contents
Executive Summary
Introduction and Methodology
Benchmarking Index
Digitally Transformed with Digital Technologies Underpinning How the Manufacturer Meets the Industry’s Challenges
GSK
AstraZeneca
Pfizer
Merck
Embedding Digital Technologies, but Digital Transformation Is Less Advanced Than Competitors
AbbVie
Amgen
Johnson & Johnson
Sanofi
Digitally Transformed, but More Scope Exists to Use Digital Technologies to Meet Industry Challenges
Novartis
Novo Nordisk
Eli Lilly
Takeda
Behind Competitors with Regard to Both Digital Transformation and Utilizing Digital Technologies to Meet the Industry’s Challenges
Roche
Bristol Myers Squibb
Gilead Sciences
Companies Mentioned
- AbbVie Inc.
- Amgen
- AstraZeneca
- Bristol-Myers Squibb
- Eli Lilly
- Gilead Sciences
- GSK
- Merck
- Novartis
- Novo Nordisk
- Pfizer
- Roche
- Sanofi
- Takeda
